How Clinicians Want Deprescribing Written Into Practice Guidelines

This qualitative study identifies the specific content, language, and format features clinicians say make deprescribing recommendations actually usable, directly relevant to how Beers Criteria and other older-adult guidance should be structured.

deprescribingclinical practice guidelinesolder adultspolypharmacypotentially inappropriate medicationsBeers CriteriaGLAFIGRADEqualitative researchimplementation sciencegeriatrics Guideline: Beers Criteria / Older Adults

Background Information

Enhancing deprescribing guidelines could improve care for older adults.

Deprescribing in older adults requires careful consideration, yet is often underrepresented in clinical guidelines. Improving this can enhance guideline effectiveness. Three themes emerged: need for higher content quality, clarity versus comprehensiveness balance, and optimal placement of recommendations. The study highlights the complexity of deprescribing compared to prescribing, urging more detailed and actionable recommendations in guidelines. Enhancing deprescribing recommendations can improve guideline implementation in older adults.

📊 Deep Analysis Available

Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.

Subscribe for Full Access →

Authors: Langford AV, Liau SJ, Loh S, Farrell B, Thompson W, Pollock D, Moriarty F, Gnjidic D, Ailabouni NJ, Reeve E

Citation: Langford AV, Liau SJ, Loh S, et al. Designing Implementable Deprescribing Recommendations: A Qualitative Study of Healthcare Professional Perspectives. Journal of general internal medicine. 2026. doi:10.1007/s11606-026-10679-x

Article Links: PubMed · Journal / DOI

🎓

Reviewed by a licensed pharmacist

Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.

Accurate and up-to-date information is our highest priority.

If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.

Suggest a correction Request a topic

Thanks for the feedback!

🔒

Deep Analysis: Subscribers Only

Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.

Executive Summary

Study Design

Patient Population

Primary Outcomes

Secondary Outcomes & Safety Profile

Pharmacist Implications

Clinical Pearls

Limitations

Controversies & Evidence Gaps

Cost & Logistics

Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →